2025. Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial". Bleeding, Thrombosis and Vascular Biology. 4, 2 (Apr. 2025). DOI:https://doi.org/10.4081/btvb.2025.179.